Our study identified approximately 11,000 stage-specific CREs that support the BCP-ALL phenotype, including 5220 CREs (selected as C1 and C2) that were active only at the onset and relapse but silent in healthy and remission samples. This evidence concerns the gene OPN1SW and acute lymphoblastic leukemia.